Count | |
3 | |
2 | |
1 | |
2 | |
1 | |
1 | |
1 | |
1 | |
1 | |
2 | |
1 | |
1 | |
3 | |
1 | |
1 | |
3 | |
1 | |
1 | |
1 | |
5 | |
1 | |
1 | |
1 | |
2 | |
2 | |
1 | |
1 | |
1 | |
1 | |
1 | |
1 | |
5 | |
2 | |
1 | |
1 | |
1 | |
1 | |
1 | |
1 | |
1 | |
1 | |
1 | |
Nitric-Oxide Synthase/antagonists & inhibitors/drug effects/*metabolism | 1 |
1 | |
6 | |
10 | |
1 | |
1 | |
3 | |
1 | |
3 | |
Arginine/adverse effects/*analogs & derivatives/blood/*drug effects | 1 |
1 | |
3 | |
1 | |
1 | |
9 | |
46 | |
34 | |
2 | |
41 | |
26 | |
4 | |
5 | |
1 | |
1 | |
167 | |
8 | |
74 | |
21 | |
127 | |
1 | |
46 | |
1 | |
2 | |
2 | |
1 | |
2 | |
1 | |
1 | |
4 | |
2 | |
16 | |
1 | |
2 | |
1 | |
77 | |
1 | |
1 | |
1 | |
3 | |
10 | |
2 | |
1 | |
2 | |
1 | |
3 | |
1 | |
Phosphoproteins/adverse effects/*antagonists & inhibitors/drug effects | 1 |
C-Reactive Protein/adverse effects/*drug effects/*metabolism | 1 |